Last reviewed · How we verify
Amyvid radiopharmaceutical
At a glance
| Generic name | Amyvid radiopharmaceutical |
|---|---|
| Sponsor | Brain Health Alliance |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Entire-body PET Scans for Multiple Sclerosis (EARLY_PHASE1)
- Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD) (NA)
- Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amyvid radiopharmaceutical CI brief — competitive landscape report
- Amyvid radiopharmaceutical updates RSS · CI watch RSS
- Brain Health Alliance portfolio CI